Jade Biosciences, Inc. (JBIO) is a Healthcare · Biotechnology company listed on NASDAQ. Price $17.17 (+0.17%), Market cap $1.09B, 52-week low–high $6.76 ~ $26.85.
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
Financial statements, price targets, institutional (13F) holdings and related news for Jade Biosciences, Inc. are updated in real time on BlackAll Trade.
Jade Biosciences, Inc. trades at $17.17 (+0.17%). Real-time quotes and charts are available on BlackAll Trade.
Jade Biosciences, Inc. has a market cap of about $1.09B.
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoc